Filing Details
- Accession Number:
- 0001493152-22-004599
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2022-02-14 18:36:36
- Reporting Period:
- 2021-12-31
- Accepted Time:
- 2022-02-14 18:36:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1552189 | Panacea Life Sciences Holdings Inc. | PLSH | Medicinal Chemicals & Botanical Products (2833) | 271085858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1866792 | Leslie Buttorff | 5910 South University Blvd, C18-193 Greenwood Village CO 80121 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-21 | 500 | $1.00 | 600,399 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2021-12-21 | 1,000 | $0.90 | 601,399 | No | 5 | P | Direct | |
Common Stock | Disposition | 2021-10-25 | 7,321,429 | $0.00 | 4,047,054 | No | 5 | D | Indirect | Held by Quintel-MC, Incorporated |
Series C-2 Preferred Stock | Acquisiton | 2021-10-25 | 100 | $0.00 | 100 | No | 5 | A | Indirect | Held by Quintel-MC, Incorporated |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | D | Indirect | Held by Quintel-MC, Incorporated |
No | 5 | A | Indirect | Held by Quintel-MC, Incorporated |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Series C Preferred Stock | 1,000,000 | Indirect | Held by Quintel-MC, Incorporated |
Series C-1 Preferred Stock | 10,000 | Indirect | Held by Quintel-MC, Incorporated |
Series D Preferred Stock | 10,000 | Indirect | Held by J&N Real Estate Company LLC |
Footnotes
- The shares of common stock were cancelled in connection with the designation of 100 shares of Series C-2 Convertible Preferred Stock to Quintel-MC, Incorporated.
- The Series C-2 designates 100 shares for issuance, par value $0.0001 per share. Each share of Series C-2 is convertible into 73,215 shares of the Company's common stock and is entitled to vote on all matters submitted to the Company's stockholders on an as-converted basis. Other than the conversion and voting rights, there are no other preferences.
- The shares of preferred stock were acquired in connection with the cancellation of 7,321,429 shares of the Company's common stock that were held by Quintel-MC, Incorporated.